Cargando…
Muscle-Specific Kinase Myasthenia Gravis
Thirty to fifty percent of patients with acetylcholine receptor (AChR) antibody (Ab)-negative myasthenia gravis (MG) have Abs to muscle specific kinase (MuSK) and are referred to as having MuSK-MG. MuSK is a 100 kD single-pass post-synaptic transmembrane receptor tyrosine kinase crucial to the devel...
Autores principales: | Borges, Lucia S., Richman, David P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225350/ https://www.ncbi.nlm.nih.gov/pubmed/32457737 http://dx.doi.org/10.3389/fimmu.2020.00707 |
Ejemplares similares
-
Inflammation and autoimmune myasthenia gravis
por: Huda, Ruksana
Publicado: (2023) -
Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics
por: Lazaridis, Konstantinos, et al.
Publicado: (2020) -
Characterization of B cells in muscle-specific kinase antibody myasthenia gravis
por: Guptill, Jeffrey T., et al.
Publicado: (2015) -
Treating muscle-specific kinase myasthenia gravis from the inside out
por: Huijbers, Maartje G., et al.
Publicado: (2019) -
Complement Inhibitor Therapy for Myasthenia Gravis
por: Albazli, Khaled, et al.
Publicado: (2020)